Gait analysis in a mouse model resembling Leigh disease

Ria de Haas1, Frans G Russel2, Jan A Smeitink3

  • 1Nijmegen Center for Mitochondrial Disorders, Department of Paediatrics, Radboud UMC, Nijmegen, The Netherlands; Nijmegen Center for Mitochondrial Disorders, Department of Pharmacology and Toxicology, Radboud UMC, Nijmegen, The Netherlands.

Behavioural Brain Research
|September 13, 2015
PubMed

Insights

Leigh disease mouse models show gait abnormalities using automated CatWalk analysis. This objective method aids in developing treatments for this rare mitochondrial disorder.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Genetics

Background:

  • Leigh disease (LD), a severe neurodegenerative disorder, stems from mitochondrial oxidative phosphorylation (OXPHOS) defects.
  • Current treatments for LD are ineffective, necessitating robust animal models for research.
  • The Ndufs4 knockout mouse model mimics human LD, displaying progressive neurodegeneration.

Purpose of the Study:

  • To evaluate the utility of automated CatWalk gait analysis in the Ndufs4(-/-) mouse model of Leigh disease.
  • To identify and quantify specific gait abnormalities indicative of neurodegeneration in this model.

Main Methods:

  • Utilized the Ndufs4 knockout mouse model, a well-established model for mitochondrial complex I deficiency.
  • Employed automated CatWalk gait analysis to objectively assess locomotion in Ndufs4(-/-) and control mice.
  • Analyzed dynamic, static, coordination, and support parameters of gait.

Main Results:

  • Ndufs4(-/-) mice exhibited significantly altered gait parameters compared to controls.
  • Increased variation in walking speed indicated hampered and uncoordinated movement.
  • Key findings included a decreased regularity index, increased base of support, and altered support parameters.

Conclusions:

  • Automated CatWalk gait analysis is a sensitive and objective tool for detecting gait abnormalities in the Ndufs4(-/-) mouse model.
  • This method can significantly aid in preclinical studies, including drug efficacy testing for Leigh disease.
  • Objective gait analysis provides valuable insights for understanding LD neuropathology and developing therapeutic strategies.

Related Concept Videos